Genetic Factors Influence Effectiveness of Gabapentin for Chronic Pain Treatment: UCLA Study Reveals
Research from UCLA suggests that genetic differences may explain why gabapentin works for some chronic pain patients but not others. The study analyzed data from over 1,000 participants and identified variants in the GABBR2 gene as potential predictors of gabapentin effectiveness. These findings could lead to personalized pain management plans, improving treatment outcomes.
View More